Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

9.533 +0.043 (+0.45%)
Streaming Delayed Price Updated: 11:41 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 216,491
Open 9.750
Bid (Size) 9.520 (3)
Ask (Size) 9.540 (3)
Prev. Close 9.490
Today's Range 9.410 - 9.790
52wk Range 2.215 - 10.04
Shares Outstanding 57,943,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rezolute to Participate in Upcoming Investor Conferences
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Rezolute, Inc.
Via GlobeNewswire

Performance

YTD
+85.1%
+85.1%
1 Month
+2.6%
+2.6%
3 Month
+54.8%
+54.8%
6 Month
+147.0%
+147.0%
1 Year
+69.3%
+69.3%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Rezolute Inc (NASDAQ:RZLT) Reports Q4 FY2025 Results, Posts Wider-Than-Expected Loss Amid Strong Clinical Progress
Via Chartmill
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
Via MarketBeat
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in Upcoming Investor Conferences
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
From Rezolute, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Participate in Upcoming Investor Conferences
From Rezolute, Inc.
Via GlobeNewswire
Rezolute, Inc. Announces Closing of Underwritten Offering
From Rezolute, Inc.
Via GlobeNewswire
Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism (“HI”)
From Rezolute, Inc.
Via GlobeNewswire
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Rezolute, Inc. - Common Stock (NV) publicly traded?
Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.
What exchange does Rezolute, Inc. - Common Stock (NV) trade on?
Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market
What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?
The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market
What is the current price of Rezolute, Inc. - Common Stock (NV)?
The current price of Rezolute, Inc. - Common Stock (NV) is 9.533
When was Rezolute, Inc. - Common Stock (NV) last traded?
The last trade of Rezolute, Inc. - Common Stock (NV) was at 10/29/25 11:41 AM ET
What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?
The market capitalization of Rezolute, Inc. - Common Stock (NV) is 552.37M
How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?
Rezolute, Inc. - Common Stock (NV) has 552M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.